Stamos Capital Partners, L.P. Regeneron Pharmaceuticals, Inc. Transaction History

Stamos Capital Partners, L.P.

  • $459 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $191,320 - $243,192
-400 Closed
0 $0
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $908,202 - $1.19 Million
-1,841 Reduced 82.15%
400 $249,000
Q1 2020

May 15, 2020
BUY
$336.18 - $494.43 $753,379 - $1.11 Million
2,241 New
2,241 $1.09 Million

Others Institutions Holding REGN

# of Institutions
1,463
Shares Held
84.5M
Call Options Held
907K
Put Options Held
1.3M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Stamos Capital Partners, L.P. Portfolio

Follow Stamos Capital Partners, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stamos Capital Partners, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Stamos Capital Partners, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email